PolyPid Ltd. (PYPD)
5.16
-0.17
(-3.19%)
USD |
NASDAQ |
Sep 15, 16:00
5.13
-0.03
(-0.58%)
After-Hours: 20:00
PolyPid Enterprise Value : 99.61M for Sept. 15, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 99.61M |
| September 14, 2026 | 103.06M |
| September 11, 2026 | 99.41M |
| September 10, 2026 | 99.61M |
| September 09, 2026 | 100.42M |
| September 08, 2026 | 103.06M |
| September 04, 2026 | 104.28M |
| September 03, 2026 | 101.85M |
| September 02, 2026 | 102.45M |
| September 01, 2026 | 103.06M |
| August 31, 2026 | 99.20M |
| August 28, 2026 | 97.78M |
| August 27, 2026 | 98.80M |
| August 26, 2026 | 98.60M |
| August 25, 2026 | 98.39M |
| August 24, 2026 | 96.06M |
| August 21, 2026 | 98.39M |
| August 20, 2026 | 97.99M |
| August 19, 2026 | 96.56M |
| August 18, 2026 | 90.88M |
| August 17, 2026 | 91.69M |
| August 14, 2026 | 91.08M |
| August 13, 2026 | 91.89M |
| August 12, 2026 | 93.11M |
| August 11, 2026 | 90.88M |
| Date | Value |
|---|---|
| August 10, 2026 | 91.69M |
| August 07, 2026 | 93.11M |
| August 06, 2026 | 92.50M |
| August 05, 2026 | 88.24M |
| August 04, 2026 | 85.19M |
| August 03, 2026 | 83.36M |
| July 31, 2026 | 81.94M |
| July 30, 2026 | 83.56M |
| July 29, 2026 | 77.67M |
| July 28, 2026 | 70.97M |
| July 27, 2026 | 75.64M |
| July 24, 2026 | 74.02M |
| July 23, 2026 | 80.92M |
| July 22, 2026 | 76.05M |
| July 21, 2026 | 70.77M |
| July 20, 2026 | 99.41M |
| July 17, 2026 | 103.88M |
| July 16, 2026 | 100.22M |
| July 15, 2026 | 100.63M |
| July 14, 2026 | 103.47M |
| July 13, 2026 | 97.17M |
| July 10, 2026 | 101.03M |
| July 09, 2026 | 104.89M |
| July 08, 2026 | 100.63M |
| July 07, 2026 | 103.06M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Teva Pharmaceutical Industries Ltd. | 58.95B |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 148.10M |
| Purple Biotech Ltd. | -3.246M |
| Sol-Gel Technologies Ltd. | 163.69M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.849M |
| Total Expenses (Quarterly) | 7.849M |
| EPS Diluted (Quarterly) | -0.3467 |
| Earnings Yield | -28.72% |
| Normalized Earnings Yield | -28.73 |